Subscribe or Manage Preferences
View Latest Issue
Charlotte, NC—Although managing rheumatoid arthritis (RA) in patients who are pregnant or trying to conceive may be challenging, rheumatologists should aim to improve disease activity and pregnancy outcomes, according to Megan E. B. Clowse, MD, MPH, Associate Professor of Medicine, Director, Duke Autoimmunity in Pregnancy Registry, Duke University Medical Center, at the North Carolina Regional Association 2014 annual meeting.
Adult patients with rheumatoid arthritis (RA) may benefit from subcutaneous methotrexate (MTX) compared with oral administration of the drug, recent study findings suggest.
Previous research suggests that gouty arthritis (GA) is associated with an increased risk for certain disorders, such as cardiovascular (CV) disease. Inger L. Meek, MD, and colleagues recently reported that hyperuricemia was associated with a 3.1-fold hazard of first CV event in patients with GA.
Patients with rheumatic, immune-­mediated, inflammatory diseases require extensive and ongoing assessments of their disease state in response to treatment, providing opportunities for nurse-patient education.
Montreal, Quebec—The healthcare costs associated with rheumatoid arthritis (RA) have been a growing cause of concern because of the chronic aspect of the disease, treatment costs, and variability in patterns of care, according to researchers.
A recent review evaluating currently available data on rheumatoid arthritis (RA) diagnosis, prognosis, and prediction of response to therapy, highlights the potential of gene expression profiling in understanding RA biology, patient management, and personalized care.
Limited data exist on the validity of diagnostic codes for psoriasis and psoriatic arthritis (PsA). A group of researcher from Sweden recently evaluated the validity of the International Classification of Diseases, Tenth Revision Systematisk Förtecking (ICD-10-SE) for both disorders in the Skåne Healthcare Register (SHR), and found that SHR was a valid healthcare register for studies on psoriasis and PsA.
Seville, Spain––Is it cost-effective to screen for osteoporosis using the prescreening Fracture Risk Assessment Tool (FRAX) scores in all women 60 years and older? In a presentation at the 2014 European Society for Clinical and Economic Aspects of Osteoporosis meeting, a group of researchers from Belgium and Holland made the case that it is cost-effective.
Tampa, FL—Researchers have detected 2 different subclusters of patients with fibromyalgia, according to results presented at the American Pain Society's 2014 Annual Meeting.
Page 1 of 3
Results 1 - 10 of 21
  • Rheumatology Practice Management
  • Lynx CME
  • American Health & Drug Benefits
  • Value-Based Cancer Care
  • Value-Based Care in Myeloma
  • Value-Based Care in Neurology